ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30

ESCALON MEDICAL CORP

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026

$0.18+0.01 (+7.65%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q4 FY2010 Ended Jun 30, 2010	Sep 29, 2010	After market close	–	–	–

Announcements Escalon Medical filed with the SEC

Parsed from the XBRL in Escalon Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Nov 24, 1997
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ESMC.

Revenue growth5.7% · median 7.3%

Gross margin43.7% · median 51.1%

Operating margin0.4% · median -104.3%

Net margin31.5% · median -108.8%

Advertisement
300 × 250